Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Opioid Overdose Hospitalizations among Medicare-Disability Beneficiaries.

Peters JL, Durand WM, Monteiro KA, Dumenco L, George P.

J Am Board Fam Med. 2018 Nov-Dec;31(6):881-896. doi: 10.3122/jabfm.2018.06.180152.

2.

Contrasting Incoming Medical Students' Attitudes Dual Degree vs Traditional Tracks.

Monteiro KA, Dietrich K, Borkan J, Dumenco L, Tunkel AR, Dollase R, George P.

Fam Med. 2018 May;50(5):372-375. doi: 10.22454/FamMed.2018.631070.

3.

Predicting United States Medical Licensure Examination Step 2 clinical knowledge scores from previous academic indicators.

Monteiro KA, George P, Dollase R, Dumenco L.

Adv Med Educ Pract. 2017 Jun 19;8:385-391. doi: 10.2147/AMEP.S138557. eCollection 2017.

4.

Proceedings from Bridging Health Disparities to Address the Opioid Epidemic: A Symposium at the Warren Alpert Medical School of Brown University.

Dumenco L, Monteiro K, Mello M, Collins S, Operario D, Scanlan K, Dollase R, George P.

R I Med J (2013). 2017 Apr 3;100(4):16-18.

PMID:
28375414
5.

An interprofessional education workshop to develop health professional student opioid misuse knowledge, attitudes, and skills.

Monteiro K, Dumenco L, Collins S, Bratberg J, MacDonnell C, Jacobson A, Dollase R, George P.

J Am Pharm Assoc (2003). 2017 Mar - Apr;57(2S):S113-S117. doi: 10.1016/j.japh.2016.12.069. Epub 2017 Jan 31.

PMID:
28159503
6.

Expanding Group Peer Review: A Proposal for Medical Education Scholarship.

Dumenco L, Engle DL, Goodell K, Nagler A, Ovitsh RK, Whicker SA.

Acad Med. 2017 Feb;92(2):147-149. doi: 10.1097/ACM.0000000000001384.

PMID:
27680319
7.

The importance of quality improvement education for medical students.

Shen B, Dumenco L, Dollase R, George P.

Med Educ. 2016 May;50(5):567-8. doi: 10.1111/medu.13039. No abstract available.

PMID:
27072451
8.

Playing in the "Gutter": Cultivating Creativity in Medical Education and Practice.

Liou KT, Jamorabo DS, Dollase RH, Dumenco L, Schiffman FJ, Baruch JM.

Acad Med. 2016 Mar;91(3):322-7. doi: 10.1097/ACM.0000000000001018.

PMID:
26630602
9.

The Primary Care-Population Medicine Program at The Warren Alpert Medical School of Brown University.

George P, Tunkel AR, Dollase R, Gruppuso P, Dumenco L, Rapoza B, Borkan J.

R I Med J (2013). 2015 Sep 1;98(9):16-21.

PMID:
26324970
10.

Future health disparity initiatives at the Warren Alpert Medical School of Brown University.

Rappaport L, Coleman N, Dumenco L, Tobin-Tyler E, Dollase RH, George P.

R I Med J (2013). 2014 Sep 2;97(9):36-9.

PMID:
25181745
11.

Health disparity curriculum at the Warren Alpert Medical School of Brown University.

Erlich M, Blake R, Dumenco L, White J, Dollase RH, George P.

R I Med J (2013). 2014 Sep 2;97(9):22-5.

PMID:
25181742
12.

Introducing technology into medical education: two pilot studies.

George P, Dumenco L, Dollase R, Taylor JS, Wald HS, Reis SP.

Patient Educ Couns. 2013 Dec;93(3):522-4. doi: 10.1016/j.pec.2013.04.018. Epub 2013 May 16.

PMID:
23684367
13.

Incorporating iPads into a preclinical curriculum: a pilot study.

George P, Dumenco L, Doyle R, Dollase R.

Med Teach. 2013;35(3):226-30. doi: 10.3109/0142159X.2012.735384. Epub 2013 Feb 20.

PMID:
23425119
14.

Curriculum innovation at the Warren Alpert Medical School of Brown University.

Dumenco L, George P, Taylor JS, Dollase R.

Med Health R I. 2012 Oct;95(10):317-8, 324-7. No abstract available.

PMID:
23155850
15.

The Warren Alpert Medical School of Brown University.

Gruppuso PA, Dollase R, Dumenco L, Taylor J, Green E.

Acad Med. 2010 Sep;85(9 Suppl):S520-4. doi: 10.1097/ACM.0b013e3181ea67ef. No abstract available.

PMID:
20736621
16.

Redesigning the medical science curriculum at the Warren Alpert Medical School of Brown University.

Garg S, Gruppuso PA, Dumenco L.

Med Health R I. 2007 Sep;90(9):272-4. No abstract available.

PMID:
17970327
17.
19.
20.
21.
22.

Determinants of O6-alkylguanine-DNA alkyltransferase activity in human colon cancer.

Gerson SL, Allay E, Vitantonio K, Dumenco LL.

Clin Cancer Res. 1995 May;1(5):519-25.

23.

The immature thymocyte is protected from N-methylnitrosourea-induced lymphoma by the human MGMT-CD2 transgene.

Zaidi NH, Allay E, Ayi TC, Li BF, Dumenco LL, Sy MS, Gerson SL.

Carcinogenesis. 1995 May;16(5):1047-53.

PMID:
7767963
24.

Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon.

Zaidi NH, Pretlow TP, O'Riordan MA, Dumenco LL, Allay E, Gerson SL.

Carcinogenesis. 1995 Mar;16(3):451-6.

PMID:
7697797
25.
26.

Alkyltransferase transgenic mice: probes of chemical carcinogenesis.

Gerson SL, Zaidi NH, Dumenco LL, Allay E, Fan CY, Liu L, O'Connor PJ.

Mutat Res. 1994 Jun 1;307(2):541-55.

PMID:
7514728
27.
28.

The prevention of thymic lymphomas in transgenic mice by human O6-alkylguanine-DNA alkyltransferase.

Dumenco LL, Allay E, Norton K, Gerson SL.

Science. 1993 Jan 8;259(5092):219-22.

PMID:
8421782
29.

Inhibition of the activation of Hageman factor (factor XII) by extracts of Schistosoma mansoni.

Foster CB, Flanigan TP, DeStigter KK, Blanton R, Dumenco LL, Gallagher C, Ratnoff OD.

J Lab Clin Med. 1992 Nov;120(5):735-9.

PMID:
1431502
30.

Comparison of the inactivation of mammalian and bacterial O6-alkylguanine-DNA alkyltransferases by O6-benzylguanine and O6-methylguanine.

Dolan ME, Pegg AE, Dumenco LL, Moschel RC, Gerson SL.

Carcinogenesis. 1991 Dec;12(12):2305-9.

PMID:
1747932
31.

Fetal liver hematopoietic stem cells as a target for in utero retroviral gene transfer.

Clapp DW, Dumenco LL, Hatzoglou M, Gerson SL.

Blood. 1991 Aug 15;78(4):1132-9.

32.

Enhanced repair of O6-methylguanine DNA adducts in the liver of transgenic mice expressing the ada gene.

Dumenco LL, Arce C, Norton K, Yun J, Wagner T, Gerson SL.

Cancer Res. 1991 Jul 1;51(13):3391-8.

33.

Inhibition of the activation of Hageman factor (factor XII) and of platelet aggregation by extracts of Brugia malayi microfilariae.

Foster CB, Flanigan TP, Kazura JW, Dumenco LL, Ratnoff OD.

J Lab Clin Med. 1991 May;117(5):344-52.

PMID:
1902251
34.
35.

High level, regulated expression of the chimeric P-enolpyruvate carboxykinase (GTP)-bacterial O6-alkylguanine-DNA alkyltransferase (ada) gene in transgenic mice.

Lim IK, Dumenco LL, Yun J, Donovan C, Warman B, Gorodetzkaya N, Wagner TE, Clapp DW, Hanson RW, Gerson SL.

Cancer Res. 1990 Mar 15;50(6):1701-8.

36.

Transgenic mice expressing the bacterial O6 alkylguanine-DNA alkyltransferase gene: an animal model to study the role of DNA repair in the carcinogenesis of N-nitroso compounds.

Dumenco LL, Donovan C, Warman B, Clapp DW, Lim IK, Yun J, Wagner T, Hanson RW, Gerson SL.

Prog Clin Biol Res. 1990;340A:369-78. No abstract available.

PMID:
2388920
37.

Increase in nitrosourea resistance in mammalian cells by retrovirally mediated gene transfer of bacterial O6-alkylguanine-DNA alkyltransferase.

Dumenco LL, Warman B, Hatzoglou M, Lim IK, Abboud SL, Gerson SL.

Cancer Res. 1989 Nov 1;49(21):6044-51.

38.

Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.

Dumenco LL, Everson B, Culp LA, Ratnoff OD.

J Lab Clin Med. 1988 Sep;112(3):394-400.

PMID:
3045234

Supplemental Content

Loading ...
Support Center